NSE SME Bookbuilding IPO Fresh Capital Closed
Curis Lifesciences Ltd. IPO 2026
₹128
Issue Price
+₹0
GMP Today
21,50,000 (100.00%)
Total Shares Offered
₹128
Est. Listing
📅
Open Date
2025-11-07
📅
Close Date
2025-11-11
🎟️
Allotment
2025-11-12
⚡
UPI Mandate
2025-11-11
📱
Listing Date
2025-11-14
🔗
Script Code
TBA
Grey Market Premium (GMP)
LIVE
Current GMP
+₹0
+0% vs Issue Price
Estimated Listing: ₹128
Issue Price: ₹128
· Lot: 1,000 shares
Expected P&L (1 lot):
+₹0
on ₹128,000
GMP is unofficial grey market data. It does not guarantee listing price or returns.
Financial Overview
Amount in ₹ Crore
| Metric | 31 Jul 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Revenue | 19.51 | 49.65 | 35.87 |
| Profit After Tax | 2.87 | 6.11 | 4.87 |
| EBITDA | 4.24 | 9.54 | 8.39 |
| Net Worth | 19.10 | 16.23 | 5.87 |
| Total Assets | 56.29 | 42.53 | 33.88 |
| Reserves & Surplus | 13.16 | 10.29 | 5.37 |
| Total Borrowings | 15.32 | 15.62 | 17.09 |
Key Financial Ratios
55.25%
ROE
Return on Equity
27.83%
ROCE
Return on Capital Employed
37.62%
RONW
Return on Net Worth
12.43%
PAT Margin
PAT / Revenue
19.41%
EBITDA Mgn
EBITDA / Revenue
0.96
D/E Ratio
Debt to Equity
12.64
P/BV
Price to Book Value
Issue Details
Total Shares Offered
21,50,000 (100.00%)
Net Offer to Public
20,42,000 shares (aggregating up to ₹26.14 Cr)
Market Maker Reservation
1,08,000 shares (aggregating up to ₹1.38 Cr)
Pre-Issue Shareholding
59,34,434 shares%
Post-Issue Shareholding
80,84,434 shares%
Issue Price
₹128
Face Value
₹10
Lot Size
1,000 shares
Listing Exchange
NSE SME
Issue Type
Bookbuilding IPO
Objects of Issue
1 Capital Expenditure towards Upgradation/Improvement of the existing Manufacturing Facilities
2 Capital Expenditure towards Construction of a Storage Facility
3 Pre-payment/Repayment of outstanding Secured Loans
4 Product Registrations in other countries
5 Funding our Working Capital Requirements
6 General Corporate Purposes
Lead Managers
Finaax Capital Advisors Private Limited
IPO Timeline
Open
2025-11-07
Close
2025-11-11
Allotment
2025-11-12
Listing
2025-11-14
Registrar Details
MUFG Intime India Pvt.Ltd.
+91-22-4918 6270
curislifesciences.smeipo@in.mpms.mufg.com
Check Allotment Status
Company Information
Website
Email
cs@curisls.com
Phone
+91 99045 22543
Address
PF-23, GIDC Sanand - II, Industrial Estate, Sanand Ahmedabad, Gujarat, 382110
About Curis Lifesciences Ltd.
Incorporated in 2010, Curis Lifesciences Limited is a pharmaceutical company that specializes in developing, manufacturing, and distributing a diverse range of products.
The company manufactures pharmaceutical products globally and domestically on a loan license or contract basis, as well as for its own brand marketing.
The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya.
Products:
- General pharmaceutical tablets and capsules
- Oral liquids
- External preparations
- Sterile ophthalmic ointments
The company operates a state-of-the-art manufacturing facility in Sanand, Gujarat, adhering to stringent quality control measures to ensure product safety and efficacy.
As of July 31, 2025, the company has 95 permanent employees.
Competitive Strengths:
- Experienced Promoters and Management Team
- Wide range of Products
- Strategic Location of Manufacturing Facility
- Scalable Business Model
- Quality assurance
Quick Facts
GMP Signal
Bullish 🚀
Status
Closed
Issue Price
₹128
Lot Size
1,000 sh
Est. Listing
₹128
Pre-Issue Hold.
59,34,434 shares%
Post-Issue Hold.
80,84,434 shares%
Registrar
MUFG Intime India Pvt.Ltd.
GMP Profit Calculator
Est. Listing
GMP %
1 Lot Investment
Total Investment
Expected P&L
ROI
U
Ariant · Sponsored
₹0 AMC · Advanced Charts
Apply SME IPOs via UPI instantly